Anna Goshua is an editorial intern at Spectrum. Previously, she interned at Medscape. She is a medical student at Stanford University and a journalism student in the Science, Health and Environmental Reporting Program at New York University.
Anna Goshua
Intern
Spectrum
From this contributor
Cluster of traits tied to rare mutations in autism-linked gene
Developmental delay, intellectual disability and behavioral issues are common among people who have mutations in MYT1L, a gene with strong ties to autism.
Cluster of traits tied to rare mutations in autism-linked gene
By
Anna Goshua
20 December 2021 | 3 min read
Pitfalls in using autism claims data: Q&A with Lindsay Shea
Insurance claims data are useful for autism research, but the field needs to standardize how they are mined, Shea says.
Pitfalls in using autism claims data: Q&A with Lindsay Shea
By
Anna Goshua
14 December 2021 | 6 min read
DNA methylation in autism, explained
How chemical tags called methyl groups position themselves on genetic sequences may hint at some of the causes of autism.
Myelin loss may explain how autism-linked DNA deletion affects cognition
Deleting a copy of the gene TBX1 depletes the fatty myelin insulation that surrounds neurons and reduces cognitive speed in mice.
Myelin loss may explain how autism-linked DNA deletion affects cognition
By
Anna Goshua
8 December 2021 | 3 min read
Dispatches from SfN 2021: Mitochondria, Rett therapy and oxytocin
These short reports from Spectrum journalists highlight some of the autism-related findings that caught our attention at the meeting this past week.
Dispatches from SfN 2021: Mitochondria, Rett therapy and oxytocin
By
Angie Voyles Askham, Laura Dattaro, Anna Goshua, Peter Hess
11 November 2021 | 9 min read
Explore more from The Transmitter
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
By
Dalmeet Singh Chawla
8 July 2026 | 5 min read
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
By
Holly Barker
8 July 2026 | 5 min read